Single cancer stem-like cells (CSCs) from colorectal cancers can be functionally identified by their ability to form large lumen-containing colonies in 3D 
are segregated in a polarised manner [2; 3; 4] . Full development of the brush border and associated cytoskeletal and enzyme activities corresponds with intestinal differentiation [5; 6] . Although cellular differentiation is ultimately deranged in colonic adenocarcinomas, colorectal tumours usually retain some degree of differentiation, such as glandular structure and expression of differentiation markers, and also frequently express brush border enriched enzymes such as DPPIV/CD26 and alkaline phosphatase [7] . The glandular form of tumours and general mucinous content are used by pathologists to help grade tumours [8] . Tumours are classed as either well/moderately differentiated or 'low grade' if they contain many 'neoplastic glands' that have a crypt like structure, or as poorly differentiated or 'high grade' if they lack such glandular structures [9] . Low grade tumours generally exhibit a better prognosis for the patient [10] .
Much evidence indicates that adenocarcinomas are driven by a subset of cells with characteristics of stem cells, including the ability to self-renew and to differentiate into all three colonic lineages [11] . We have previously shown that a sub-population of single cells derived from certain colorectal cell lines can, when grown for several weeks under 3D conditions, form either large crypt like structures consisting of polarised cells surrounding a cell-free lumen, or instead form small non-lumen colonies [12; 13; 14; 15] . The large lumen colonies express differentiation markers for all three-colon cell lineages, indicating the Author Manuscript Published OnlineFirst on July 18, 2013; DOI: 10.1158/0008-5472.CAN- multi-potent nature of the original cell. Single cells derived from large lumen colonies were capable of forming new large lumen colonies as well as small non-lumen colonies; whereas cells derived small non-lumen colonies could only give rise to further small colonies [14] . Lumen colony derived cells were also more tumorigenic in mouse xenografts than cells derived from small non-lumen colonies. The proportion of cells that give rise to lumen colonies could be increased by enrichment of cells with high expression of the stem cell markers CD44/CD24 [14] . Collectively, these characteristics indicate that lumen formation is driven by high clonogenic cancer stem cells that can be derived from lumen forming cell lines. Low clonogenic cells are unable to give rise to large lumen colonies, and form small non-lumen colonies. Therefore, formation of lumens from single cells can be used to characterise cancer stem cell differentiation.
Interestingly, some colorectal cell lines such as DLD1 do not differentiate under three-dimensional conditions, and instead form disorganised colonies [14; 15] .
These cell lines retain self-renewal capacity of stem cells but lack the ability to fully differentiate and are correspondingly more aggressive in xenografts and more clonogenic than lumen forming cell lines [14] . One possibility is that differentiation is inhibited in these lines by reduced expression of key transcription factors such as CDX1. CDX1 is gut transcription factor crucial to colorectal differentiation [16; 17] , and it controls the transcription of a number of intestinal differentiation markers including villin [18] , cytokeratin 20 [16] and FABP1 [19] . In colorectal cancers CDX1 is frequently transcriptionally silenced by promoter methylation [16; 17] .
In this study we have characterised the nature of differentiation of 3D colonies formed by different cell line and primary tumour derived cancer stem cells.
Methods

Cell culture
Details of cell line origins and validation can be found in supplementary text.
All cell lines were cultured in complete DMEM supplemented with 10% FBS and 1% penicillin/ streptomycin (Invitrogen). Hypoxic cells were grown in humidified 1% oxygen and 10% CO 2 environment using a MiniGalaxy incubator (RS Biotech Ltd). Medium was replaced two times per week after being pre-warmed and equilibrated overnight in 1% oxygen. For DMOG treatment, culture medium containing 2mM DMOG or DMSO (vehicle control) was overlaid over the gels and this was changed every 24 hours.
For primary culture, six moderate/well differentiated tumour specimens, obtained from fully consenting donors under National Research Ethics study, 07/H0606/120, were mechanically disrupted into small pieces and cultured in serum free medium (Excell-620, Sigma-Aldrich Ltd.) supplemented with 2% 
F-actin Assay of Colonies Grown in Matrigel.
Single cell suspensions were achieved by FACS or filtration through 30 and 20 μm filters (Celltrics, Partec GmbH). 500 cells were suspended in 40μl of an icecold mixture of Matrigel and diluted 1:1 with ice cold DMEM medium. Cell suspensions were seeded in triplicate into 96 well plates pre-coated with a solidified 1:1 Matrigel/DMEM layer (20μl per well). Overlaid Matrigel was allowed to set for 20 minutes at 37 o C and culture medium was then added to the wells. Colonies were grown for two weeks, unless otherwise specified, with medium changes every three days. The medium was removed and 100μl of 4% (v/v) paraformaldehyde in phosphate buffered saline (PBS) was added for 20 minutes. Fluid was then removed and 100 μl of PBS containing 1:200 dilution of Triton-x were added for 10 minutes. The fluid was removed and the wells were washed 4 times with 50 mM glycine in PBS. 100μl TRITC-Phalloidin diluted at 1:1000 in PBS was added incubated at 4 o C overnight. The colonies diamidino-2-phenylindole (DAPI, Sigma), in PBS were added to each well and the plate was imaged using a Zeiss LSM510 laser scanning confocal microscope (Carl Ziess Ltd, UK).
FACS Analysis
Cells were harvested and 1 x 10 6 cells and labelled with anti-CD44 and anti-CD24. Cell viability was assessed with Sytox Blue. Cells were run on a Dako
MoFLow cytometer. Gates were set to exclude dead cells, debris and doublets and the top or bottom 5% of gated CD44/CD24 (see figure 3 ) labelled cells were collected into separate tubes containing 200μl ice cold DMEM. Cells were then embedded in Matrigel as described above and assayed after 2 weeks growth.
Western Blotting
Western blot was performed on cell lysates as described previously [20] .
In Vivo Tumorigenic Assays
Single cells were injected s.c. into the flanks of 6-to 10-week-old female NOD/SCID immunodeficient mice, obtained from the John Radcliffe Hospital Biomedical Services, Oxford, United Kingdom as described in [14] . Animal studies were conducted according to the University of Oxford institutional guidelines and within the limits of the Project License issued by the Home Office, United Kingdom.
Research. Further details of materials and methods can be found in the supplementary data.
Results
Lumen Characterisation
F-actin (filamentous actin) was identified as a useful marker of lumens by staining normal human colon cryosections with fluorescent phalloidin, which is specific for F-actin ( Figure 1A ). In normal colon, F-actin is intensely enriched at the apical surface of enterocytes lining the crypt, corresponding to the brush border, presumably due to the presence of microvilli on colonic enterocytes [21; 22] . We next examined F-actin labelling in single cell derived colonies from a panel of six colon cancer cell lines, grown in a three dimensional Matrigel matrix for 2 weeks. In an SW1222 colony, confocal Z-sectioning showed intense F-actin labelling on the apical cell membranes facing the lumen, which was surrounded by polarised cells expressing cytokeratin 20 on their basolateral membranes ( Figure 1B) . LS180, SW1222, and C80 formed colonies consisting of polarised cells surrounding central lumens visible by light microscopy ( Figure 1C ). All phase visible lumens were clearly labelled by intense F-actin staining. HT29, HCT116 and DLD1, did not form observable lumen colonies using phase contrast, and did not exhibit organised bright foci of F-actin We next examined whether other intestinal brush border markers were also present in lumens. Villin, an F-actin interacting protein associated with intestinal differentiation, was strongly enriched in lumens and its staining overlapped that for F-actin (Figure 2A ). HCT116 and DLD1 did not express Villin. In HT29, villin was generally expressed but it was not polarised and did not overlap F-actin. Ezrin, another F-actin interacting protein enriched in the brush border, was also strongly enriched in lumens where it was clearly located at the apical cell membrane ( Figure 2B ). Ezrin was only weakly present at nonapical plasma membranes. Ezrin was strongly expressed in HCT116 in a nonpolarised manner.
The brush border enzyme CD26/dipeptidyl peptidase-4 (DPPIV) [7] , and the brush border enriched tight junction marker Zo-1 [23] were also polarised and enriched in lumen apical membranes (supplementary Figures 2A and B) . In 
Cancer stem cell enrichment
To determine whether stem cell enriched cell fractions gave rise to increased frequencies of lumens with F-actin/brush border differentiation we FACS sorted SW1222 and LS180 cells according to expression of cancer stem cell markers CD24 and CD44, as described previously [14] . Single sorted cells were then plated in Matrigel and grown into colonies for 2 weeks. In figure 3A To confirm that CDX1 down-regulation could impair F-actin lumen formation we used an LS174T derivative cell line 'LS174T-CDX1' with stable expression of a construct encoding a shRNA targeting CDX1, in which CDX1 was downregulated by RNAi [16] . An LS174T line, 'LS174T-Vector' expressing an empty vector was used as a control, as these cells maintain normal CDX1 levels. Single cells from either LS174T siCDX1 or LS174T Vector were embedded in Matrigel and allowed to grow into colonies for 10 days, before fixation and phalloidin labelling to visualise F-actin. Figure 6A /B shows that low CDX1 significantly reduced the proportion of colonies with well-defined Factin lumens. We also manually quantified the total number of lumens per colony in the same data, and found that CDX1 knock down also reduced this number ie CDX1 knockdown inhibited lumens per colony ( Figure 6C ). We next took advantage of the CDX1 RNAi F-actin data to validate a semi-automatic approach to lumen formation that would facilitate high-throughput analysis of stem cell differentiation using public ImageJ software. Figure 6Di 
contained F-actin labelled SW1222 colonies grown in three-dimensional conditions. ImageJ software was then used to automatically recognise and analyse the colonies (Figure 6Dii) . The software was able to detect lumens accurately in a well-differentiated colony and was able to distinguish that colony from a poorly differentiated colony lacking F-actin foci ( Figures 6D iii   and iv, respectively) . To validate this approach we used our semi-automatic method to analyse the LS174t-Vector and LS174t-CDX1 colonies manually counted in figure 6C , and found a good correlation between the automated and manual analyses ( Figure 6E ). Thus our approach enables tissue plate wells to be automatically scanned and analysed for changes in lumen formation.
Lumen formation is a feature of tumours in vivo
To determine if lumen formation had relevance to tumours in vivo, we first 
Actin and ezrin immune-labelling showed that neither HT29 nor HCT116 exhibited polarisation of these markers, whereas SW1222 showed marked luminal polarisation. Thus in vivo, cell lines grow in a manner similar to in vitro growth in Matrigel.
Because similar glandular structures ('neoplastic glands') are a feature of human colorectal adenocarcenomas, and are used by pathologists to grade tumours, we examined if they labelled with the same markers as in vitro lumens. We compared two colorectal tumours that had been graded previously One possible explanation for this is that these cells lack expression of CDX1 [16] , and this may disrupt their ability to efficiently polarisation and differentiate. Ectopic re-expression of CDX1 in HCT116 and DLD1 can lead to the formation of primitive lumens in Matrigel [14; 15] . Correspondingly, CDX1 and the related transcription factor CDX2 have been shown to be important for polarisation of intestinal cells [29; 30] . A lack of polarisation and differentiation will lead to an increase in the population of stem cells, and indeed we have found previously that HCT116 does not contain subpopulations of cells with different tumour-forming capacity, unlike the lumen forming lines [14] .
Similarly, high grade tumours have a significantly worse clinical prognosis, and exhibit a more 'stem like' transcription profile [31; 32] .
Tumour formation is frequently associated with hypoxia and our previous studies have shown that prolonged hypoxia inhibits lumen formation [15] . to hypoxia/DMOG treatment is triggered by a loss of CDX1. This is supported by the observation that targeted knockdown of CDX1 in LS174T cells leads to a significant reduction in the size and intensity of F-actin labelled lumens.
However we cannot rule out a role for other hypoxia regulated transcription factors differentiation suppression.
Specific cancer stem cell markers remain elusive. Whilst markers such as LGR5 [33] , ephrin type-B receptor 2 (EphB2) [34] , and Lrig1 [35] appear to mark well defined stem cell populations in normal intestine, their expression in tumours does not appear to be entirely specific to cancer stem cells as low clonogenic cells are also marked, at least for EphB2 [31] , and LGR5 [36; 37] . 
In summary, we have characterised the formation of lumen colonies from cell line derived single cells to represent brush border/enterocyte differentiation and shown the extent of heterogeneity between cell lines and primary tumour cultures. Thus, the cancer stem cells from the cell lines, in their ability to form lumen colonies, have a striking similarity to normal intestinal stem cells, which also divide to form the colonic crypt.
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Single cells from various cell lines were grown in Matrigel for six days.
Colonies were labelled with TRITC phalloidin (red) to visualise F-actin and DAPI to visualise nucleii. Bar 10 μm. 
